Combined Angiotensin Inhibition for CKD: The Truth Is Rarely Pure and Never Simple
- PMID: 38069999
- PMCID: PMC12085227
- DOI: 10.1053/j.ajkd.2023.10.003
Combined Angiotensin Inhibition for CKD: The Truth Is Rarely Pure and Never Simple
Comment on
-
Urinary Biomarkers and Kidney Injury in VA NEPHRON-D: Phenotyping Acute Kidney Injury in Clinical Trials.Am J Kidney Dis. 2024 Feb;83(2):151-161. doi: 10.1053/j.ajkd.2023.07.012. Epub 2023 Sep 17. Am J Kidney Dis. 2024. PMID: 37726051 Free PMC article.
References
-
- Levin A, Stevens PE, Bilous RW, et al. Kidney disease: Improving global outcomes (KDIGO) CKD work group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl. 2013;3(1):1–150. doi:10.1038/kisup.2012.73 - DOI
-
- Fossa AA, Depasquale MJ, Ringer LJ, Winslow RL. Synergistic effect on reduction in blood pressure with coadministration of a renin inhibitor or an angiotensin-converting enzyme inhibitor with an angiotensin II receptor antagonist. Drug Dev Res. 1994;33(4):422–428. doi:10.1002/ddr.430330405 - DOI
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
